Peter Libby
Peter Libby
Professor of Medcine Harvard Medical School
Verified email at
Cited by
Cited by
Inflammation and atherosclerosis
P Libby, PM Ridker, A Maseri
Circulation 105 (9), 1135-1143, 2002
Braunwald's heart disease e-book: A textbook of cardiovascular medicine
RO Bonow, DL Mann, DP Zipes, P Libby
Elsevier Health Sciences, 2011
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ...
New England journal of medicine 359 (21), 2195-2207, 2008
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ...
Circulation 108 (14), 1664-1672, 2003
Progress and challenges in translating the biology of atherosclerosis
P Libby, PM Ridker, GK Hansson
Nature 473 (7347), 317-325, 2011
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management
JA Beckman, MA Creager, P Libby
Jama 287 (19), 2570-2581, 2002
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
ZS Galis, GK Sukhova, MW Lark, P Libby
The Journal of clinical investigation 94 (6), 2493-2503, 1994
Molecular bases of the acute coronary syndromes
P Libby
Circulation 91 (11), 2844-2850, 1995
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ...
Jama 295 (13), 1556-1565, 2006
The immune response in atherosclerosis: a double-edged sword
GK Hansson, P Libby
Nature reviews immunology 6 (7), 508-519, 2006
Inflammation in atherosclerosis
P Libby
Arteriosclerosis, thrombosis, and vascular biology 32 (9), 2045-2051, 2012
Current concepts of the pathogenesis of the acute coronary syndromes
P Libby
Circulation 104 (3), 365-372, 2001
Pathophysiology of coronary artery disease
P Libby, P Theroux
Circulation 111 (25), 3481-3488, 2005
Inflammation in atherosclerosis: from pathophysiology to practice
P Libby, PM Ridker, GK Hansson, ...
Journal of the American college of cardiology 54 (23), 2129-2138, 2009
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
M Nahrendorf, FK Swirski, E Aikawa, L Stangenberg, T Wurdinger, ...
The Journal of experimental medicine 204 (12), 3037-3047, 2007
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
FK Swirski, M Nahrendorf, M Etzrodt, M Wildgruber, V Cortez-Retamozo, ...
Science 325 (5940), 612-616, 2009
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
R De Caterina, P Libby, HB Peng, VJ Thannickal, TB Rajavashisth, ...
The Journal of clinical investigation 96 (1), 60-68, 1995
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor–deficient mice
L Gu, Y Okada, SK Clinton, C Gerard, GK Sukhova, P Libby, BJ Rollins
Molecular cell 2 (2), 275-281, 1998
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
S Jaiswal, P Natarajan, AJ Silver, CJ Gibson, AG Bick, E Shvartz, ...
New England Journal of Medicine 377 (2), 111-121, 2017
The system can't perform the operation now. Try again later.
Articles 1–20